US Stock MarketDetailed Quotes

NRSN NeuroSense Therapeutics

Watchlist
  • 0.732
  • -0.029-3.75%
Close Jul 19 16:00 ET
  • 0.760
  • +0.028+3.88%
Pre 06:54 ET
13.20MMarket Cap-786P/E (TTM)

NeuroSense Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NeuroSense Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.35

-40.00%
Analyst Rating

Buy

May 24, 2024

NeuroSense Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

NeuroSense Therapeutics Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Jun 24 09:25 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Jun 17 17:26 ET

  • NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 12 16:33 ET

  • NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 5 09:33 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 24, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg